Literature DB >> 6712275

Amoxycillin and clavulanic acid in the treatment of urinary infection.

L G Al Roomi, A M Sutton, F Cockburn, T A McAllister.   

Abstract

The pharmacokinetics and clinical efficacy of amoxycillin combined with clavulanic acid in the treatment of 32 children with urinary tract infection were studied. Twenty one (80%) of 26 children with proved urinary tract infection showed a favourable clinical and bacteriological response. Fifteen of these children had amoxycillin resistant organisms and were treated successfully. In 20 children the serum and urine concentrations of amoxycillin and clavulanic acid were measured after the first oral dose.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6712275      PMCID: PMC1628547          DOI: 10.1136/adc.59.3.256

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  9 in total

1.  Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.

Authors:  C Reading; M Cole
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

2.  Prevalence of urinary tract infection in children of preschool age.

Authors:  R Boothman; M Laidlaw; I D Richards
Journal:  Arch Dis Child       Date:  1974-12       Impact factor: 3.791

3.  Adverse effects of orally administered ampicillin.

Authors:  J W Bass; D M Crowley; R W Steele; F S Young; L B Harden
Journal:  J Pediatr       Date:  1973-07       Impact factor: 4.406

Review 4.  Experience with amoxicillin: an overall summary of clinical trials in the United States.

Authors:  P J Wise; H C Neu
Journal:  J Infect Dis       Date:  1974-06       Impact factor: 5.226

5.  Enterobacter resistant to amoxycillin/clavulanate.

Authors:  J Crump; S Cansdale
Journal:  Lancet       Date:  1982-08-28       Impact factor: 79.321

6.  Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study.

Authors:  A P Ball; A M Geddes; P G Davey; I D Farrell; G R Brookes
Journal:  Lancet       Date:  1980-03-22       Impact factor: 79.321

Review 7.  The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics.

Authors:  R B Sykes; M Matthew
Journal:  J Antimicrob Chemother       Date:  1976-06       Impact factor: 5.790

8.  Treatment of chancroid by clavulanic acid with amoxycillin in patients with beta-lactamase-positive Haemophilus ducreyi infection.

Authors:  M V Fast; H Nsanze; L J D'Costa; F A Plummer; P Karasira; I W Maclean; A R Ronald
Journal:  Lancet       Date:  1982-09-04       Impact factor: 79.321

9.  Penicillins in perspective.

Authors:  T A McAllister
Journal:  Scott Med J       Date:  1982       Impact factor: 0.729

  9 in total
  3 in total

1.  Primary care management of urinary tract infection in children.

Authors:  P Lee
Journal:  Br J Gen Pract       Date:  1991-08       Impact factor: 5.386

Review 2.  Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

3.  Pharmacokinetics of Clavulanic Acid in the Pediatric Population: A Systematic Literature Review.

Authors:  Fleur M Keij; Gerdien A Tramper-Stranders; Birgit C P Koch; Irwin K M Reiss; Anouk E Muller; René F Kornelisse; Karel Allegaert
Journal:  Clin Pharmacokinet       Date:  2022-03-31       Impact factor: 5.577

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.